PTK2 and central nervous system cancer: Concordantly,inhibition of FAK kinase activity by the investigational small molecule TAE226 reduced the invasive properties of human U-87 MG, U251, and LN18 glioma cells by more than 50% [17], suggesting that FAK activation decisivelypromotes migration and invasion also of glioma cells.